Company Valuation: Ovoca Bio plc

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 11.31 8.193 14.08 4.483 0.8459 1.578
Change - -27.56% 71.86% -68.16% -81.13% 86.55%
Enterprise Value (EV) 1 1.236 -2.553 7.487 0.7799 -2.491 -0.9279
Change - -306.6% 393.3% -89.58% -419.42% 62.75%
P/E ratio -7.21x -3.5x -2.57x -0.8x -0.18x -2.12x
PBR 0.51x 0.44x 1.05x 0.59x 0.34x 0.77x
PEG - -0.1x -0x -0.32x 0x 0x
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.55x 1.2x -1.3x -0.22x 4.54x -18.2x
EV / EBIT -0.53x 1.16x -1.28x -0.2x 2.93x 3.73x
EV / FCF -0.66x 1.9x -2.83x -0.32x -42x 1.7x
FCF Yield -152% 52.6% -35.3% -312% -2.38% 58.8%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0577 -0.086 -0.2014 -0.2064 -0.173 -0.0274
Distribution rate - - - - - -
Net sales - - - - - -
EBITDA 1 -2.241 -2.134 -5.776 -3.617 -0.549 0.051
EBIT 1 -2.315 -2.205 -5.86 -3.967 -0.849 -0.249
Net income 1 -1.569 -2.336 -5.475 -5.612 -4.702 -0.746
Net Debt 1 -10.08 -10.75 -6.594 -3.703 -3.337 -2.506
Reference price 2 0.4160 0.3014 0.5179 0.1649 0.0311 0.0580
Nbr of stocks (in thousands) 27,188 27,188 27,188 27,188 27,188 27,188
Announcement Date 6/26/20 6/24/21 6/30/22 6/30/23 6/28/24 6/25/25
1EUR in Million2EUR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
42.29x9.88x35.66x0.03% 44.3B
15.95x5.66x12.46x1.87% 40B
-53.27x18x-59.42x-.--% 30.95B
-25.81x4.24x-11.69x-.--% 25.58B
27.26x5.62x15.59x-.--% 18.76B
22.65x4.6x16.19x-.--% 16.89B
-293.35x24.23x1418.21x-.--% 12.02B
-12.51x5937.57x-16.97x-.--% 11.58B
-154.44x37.64x-149.51x-.--% 11.03B
Average -47.91x 671.94x 140.06x 0.21% 23.46B
Weighted average by Cap. -20.27x 336.32x 74.41x 0.36%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA